Ledger.Open graph →
SEC Form D · Amendment · filed August 29, 2017

TORQUE THERAPEUTICS, INC

Offering
$35.0M
Sold
$21.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

John B. Dineen · Cambridge, MADirectorDoug B. Cole · CAMBRIDGE, MADirectorUlrik B. Nielsen · CAMBRIDGE, MAExec · Director · PromoterBart B. Henderson · Cambridge, MAExec · DirectorDoug B. Lauffenburger · Cambridge, MADirectorJohn B. Dineen · Cambridge, MADirectorKeith B. Marshall · Cambridge, MAExecDoug B. Cole · CAMBRIDGE, MADirectorUlrik B. Nielsen · CAMBRIDGE, MAExec · Director · PromoterBart B. Henderson · Cambridge, MAExec · DirectorVikas B. Sinha · Cambridge, MADirectorDoug B. Lauffenburger · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗